Moreover, it will be important for future studies to cross-validate our fitted SuStaIn model using another independent neuroimaging dataset but these validations are currently challenging given the lack of samples of phenotypically well-characterized, autopsy- or genetically confirmed TDP-43 proteinopathies. The gene discussed is TARDBP; the disease is proteostasis deficiencies.